Navigation Links
Addex Achieves Statistically Significant Outcome in Phase IIa,Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease

N = 11 % time pH>4 in 24h 96.5 92.8 0.014 (Primary endpoint) % time pH>4 nocturnal 96.3 90.3 0.0028 Total duration reflux 40 86 0.0132 pH<4 24h (min) Total duration reflux 16.2 48.6 0.0021 pH<4 nocturnal (min) No. symptomatic 1.9 7.0 0.031 episodes Duration symptomatic 5.2 13.9 0.031 episodes (min)

Professor Jan Tack, Professor of Medicine at the Department of Pathophysiology, Gastroenterology Section of the University of Leuven, Belgium, commented: "In spite of the clinical successes of acid-suppressive therapy, there remains a significant unmet need in our ability to manage symptoms of GERD disease. To overcome limitations of acid-suppressive drugs, which eliminate only the acid component of reflux disease, drugs that inhibit reflux events are needed. These results, in keeping with previous animal studies, provide the first confirmation that mGluR5 inhibition is able to significantly reduce reflux events and symptoms in GERD patients. The magnitude of the effect on reflux time and symptoms suggest a potential for ADX10059 to become a major addition to our therapeutic options in GERD."

"ADX10059 is the first compound with this mode of action to have demonstrated significant therapeutic potential in GERD in man," said Dr Vincent Mutel, CEO of Addex. "Brought into clinical trials exactly 2 years after its discovery, it has the potential to become a breakthrough therapy in the management of this very common condition for which there is an important unmet medical need."

About GERD

GERD is estimated to affect 15% of the adult population in the US. The proton pump inhibitors (PPIs) are the market leaders, with annual worldwide sales of approximately $16 billion. Their mechanism of action in GERD is indi
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine
2. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
3. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
4. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
7. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
8. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
11. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
Post Your Comments:
(Date:8/30/2015)... August 30, 2015 La ... l cuidado al paciente ...   Royal Philips  (NYSE: PHG, ... IntelliSpace Cardiovascular , un sistema web de gestión ... acceder, analizar y compartir imágenes cardiovasculares e información en ...
(Date:8/29/2015)... y LONDRES, August 29, 2015 ... Inteligencia Anatómica para los sistemas de imagen ... reproducibles en Ecografía, tiempos de examen rápidos y un ... en mayor confianza diagnóstica en el proceso de detección ... PHG, AEX: PHIA) ha anunciado hoy el lanzamiento europeo ...
(Date:8/28/2015)... -- With the heroin epidemic in the United ... -based Lakeview Health drug and alcohol treatment center,s ... why fentanyl is causing a new wave of overdoses. ... potent than pharmaceutical grade heroin and often illegally purchased ... death skyrockets. "Fentanyl can be an important ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
... DIEGO, Nov. 24 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ... Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, 2009 ... is being held at The New York Palace Hotel. ... will provide an overview of Anadys and its clinical development ...
... , POTOMAC, Md., Nov. 24 In ... has added Philadelphia jurors to her Thanksgiving gratitude list. ... I am so thankful to them," she said of Monday,s ... , Wisneski is among 12,000 women nationwide who have sued ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2
(Date:8/29/2015)... ... August 29, 2015 , ... ... extend and improve the lives of patients, according to a newly published report. ... to read the full article. , The authors of the new paper ...
(Date:8/29/2015)... Viejo, CA (PRWEB) , ... August 29, 2015 , ... ... Pro X . Each preset contains 15 seconds of unique footage that users can ... that rise, fall, zoom, attract and more. Users can customize color, brightness, scale, speed, ...
(Date:8/29/2015)... TX (PRWEB) , ... August 29, 2015 , ... ... allows the company to freely market and sell Arterosil and Arterosil HP, and ... Health Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United Methodists ... celebrate children helping children, a thank you to the many creative and generous ... to the United Methodist initiative to end malaria deaths. , The Columbus Zoo ...
(Date:8/28/2015)... ... August 28, 2015 , ... For Dallas, the time ... part with their subsidiary USPI Tenet Health. , The American Heart Association hosts their ... and stroke. They believe that together, a difference can be made. Walkers can participate ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2
... &,Johnson will participate in the 28th Annual Cowen ... at the Boston Marriott Copley Place,Hotel in Boston, ... the Company in a session scheduled at 11:00,a.m. ... to investors and other interested parties,by accessing the ...
... of evidence suggests the medications speed tumor growth, shorten ... a U.S. Food and Drug Administration advisory panel meets ... use in cancer patients suffering from anemia, the question ... , According to FDA briefing documents filed this week, ...
... 800% heading into spring, PORT WASHINGTON, N.Y., March ... falling apart. Due to unemployment, foreclosures and gas at,an ... their wallets.,People are becoming more and more apprehensive about ... programs. Consumers are,having a tough time trying to justify ...
... Big at Arnold Classic; Says ... -, PHOENIX, March 13 NutraCea (OTC Bulletin,Board: ... nutrient,research and technology announced today that champion powerlifter Mike,Bridges, ... with a squat lift of 716 pounds in the ...
... for ... remote workforce, ... health insurance organization, sought a trusted,method to enable secure enterprise ... Universa selected Entrust,Inc. (Nasdaq: ENTU ) and the Entrust ...
... eScriptMessenger Eases Compliance with Upcoming Federal Mandates, ... the leading provider,of next generation healthcare connectivity ... has selected Kryptiq,s eScriptMessenger(TM),(eSM) as its enterprise ... to date, will enable BMC prescribers to ...
Cached Medicine News:Health News:FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients 2Health News:FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients 3Health News:Lose Weight This Spring With Portion Control Diet Tool 2Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 2Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 3Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 4Health News:Enabling the Mobile Workforce ... Entrust Deploys Strong Authentication for German Health Insurance Expert 2Health News:Enabling the Mobile Workforce ... Entrust Deploys Strong Authentication for German Health Insurance Expert 3Health News:Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution 2Health News:Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution 3
9 mm diameter pigtail curved blunt probes. Stainless steel. Round knurled handle with polished finish. Includes pre-cut polyethylene tubes. Overall length: 5.9 inches....
The Novus 2000 argon laser combines power, size, and versatility. Ideal for the office, clinic and operating room environments, Novus 2000 is the world's most widely accepted ophthalmic laser....
Practice-oriented ophthalmic laser systems for photodisruption....
... determining color vision abnormalities and testing color ... applied to many psychological and industrial color ... trays containing a total of 85 removable ... variation on one side and are numbered ...
Medicine Products: